Journal article · 2025

Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9

Katrina L. Jackson, Ning Yin, Roman V. Agafonov, Prasoon Chaturvedi, Kyle S. Cole, Scott J. Eron, Andrew C. Good, June A. Hart, Minsheng He, Christina S. Henderson, Hongwei Huang, R. Jason Kirby and 16 more

Journal of Medicinal Chemistry, 68(23), 24848–24868 · Published 24 November 2025 · DOI 10.1021/acs.jmedchem.5c01317

View at the publisherCite this paper

In brief

“Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9” is a 2025 journal article by Katrina L. Jackson and 27 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 25 citations as of 17 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
25
Most cited in
2026 (24)
Field-weighted impact
5.27
References
39
Authors
28

Abstract

The chromatin factor bromodomain-containing protein 9 (BRD9) is a genetic dependency in SMARCB1-perturbed or SMARCB1-null cancers including synovial sarcoma. In such cancers, the degradation of BRD9 is hypothesized to result in an anticancer effect. Here, we report the discovery and characterization of CFT8634, an orally bioavailable heterobifunctional degrader that mediates potent and selective proteasomal degradation… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Jackson, K. L., Yin, N., Agafonov, R. V., Chaturvedi, P., Cole, K. S., Eron, S. J., Good, A. C., Hart, J. A., He, M., Henderson, C. S., Huang, H., Kirby, R. J., Lee, L., Moustakim, M., Nasveschuk, C. G., Phillips, A. J., Pollock, R. M., Poling, L. L., Veits, G. K., . . . Fisher, S. L. (2025). Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9. Journal of Medicinal Chemistry, 68(23), 24848–24868. https://doi.org/10.1021/acs.jmedchem.5c01317

MLA 9

Jackson, Katrina L., et al. “Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9.” Journal of Medicinal Chemistry, vol. 68, no. 23, 2025, pp. 24848–24868. https://doi.org/10.1021/acs.jmedchem.5c01317.

Chicago

Jackson, Katrina L., Ning Yin, Roman V. Agafonov, Prasoon Chaturvedi, Kyle S. Cole, Scott J. Eron, Andrew C. Good, et al. 2025. “Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9.” Journal of Medicinal Chemistry 68 (23): 24848–24868. https://doi.org/10.1021/acs.jmedchem.5c01317.

Harvard

Jackson, K. L. et al. (2025) ‘Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9’, Journal of Medicinal Chemistry, 68(23), pp. 24848–24868. doi:10.1021/acs.jmedchem.5c01317.

IEEE

K. L. Jackson et al., “Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9,” Journal of Medicinal Chemistry, vol. 68, no. 23, pp. 24848–24868, 2025, doi: 10.1021/acs.jmedchem.5c01317.

BibTeX

@article{jackson2025discovery,
  title     = {{Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9}},
  author    = {Jackson, Katrina L. and Yin, Ning and Agafonov, Roman V. and Chaturvedi, Prasoon and Cole, Kyle S. and Eron, Scott J. and Good, Andrew C. and Hart, June A. and He, Minsheng and Henderson, Christina S. and Huang, Hongwei and Kirby, R. Jason and Lee, Linda and Moustakim, Moses and Nasveschuk, Christopher G. and Phillips, Andrew J. and Pollock, Roy M. and Poling, Laura L. and Veits, Gesine K. and Yap, Jeremy Y. and Zeid, Rhamy and Ali, Amro Mohammed Moness and Crystal, Adam and Hurh, Eunju and Liu, Huan and Lobbardi, Riadh and Reyno, Leonard M. and Fisher, Stewart L.},
  journal   = {Journal of Medicinal Chemistry},
  year      = {2025},
  volume    = {68},
  number    = {23},
  pages     = {24848--24868},
  doi       = {10.1021/acs.jmedchem.5c01317},
  url       = {https://doi.org/10.1021/acs.jmedchem.5c01317}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • BRD9
  • heterobifunctional degraders
  • proteasomal degradation
  • synovial sarcoma
  • oral bioavailability
  • pharmacokinetics
  • pharmacodynamics
  • cardiotoxicity

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Jackson, K. L., Yin, N., Agafonov, R. V., Chaturvedi, P., Cole, K. S., Eron, S. J., Good, A. C., Hart, J. A., He, M., Henderson, C. S., Huang, H., Kirby, R. J., Lee, L., Moustakim, M., Nasveschuk, C. G., Phillips, A. J., Pollock, R. M., Poling, L. L., Veits, G. K., . . . Fisher, S. L. (2025). Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9. Journal of Medicinal Chemistry, 68(23), 24848–24868. https://doi.org/10.1021/acs.jmedchem.5c01317

How many times has this paper been cited?

25 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Katrina L. Jackson, Ning Yin, Roman V. Agafonov, Prasoon Chaturvedi, Kyle S. Cole, Scott J. Eron, Andrew C. Good, June A. Hart, Minsheng He, Christina S. Henderson, Hongwei Huang, R. Jason Kirby and 16 more.

What is the DOI of this paper?

10.1021/acs.jmedchem.5c01317, permanently at https://doi.org/10.1021/acs.jmedchem.5c01317. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.